PT - JOURNAL ARTICLE AU - Saito, Jien AU - Muto, Masahiro AU - Tada, Masafumi AU - Yokota, Isao AU - Kamiya, Shinji AU - Numata, Yukihide AU - Sasaki, Hideki AU - Hashizume, Takuya AU - Asano, Miki AU - Wakasa, Satoru TI - A novel use of diffusion-weighted whole-body magnetic resonance imaging with background body signal suppression to diagnose infectious aortitis AID - 10.1101/2024.03.11.24304138 DP - 2024 Jan 01 TA - medRxiv PG - 2024.03.11.24304138 4099 - http://medrxiv.org/content/early/2024/03/13/2024.03.11.24304138.short 4100 - http://medrxiv.org/content/early/2024/03/13/2024.03.11.24304138.full AB - Background Diffusion-weighted whole-body imaging with background body signal suppression is one of the whole-body magnetic resonance imaging techniques and is effective in diagnosing inflammatory and infectious diseases. We aimed to evaluate the diagnostic performance of this modality in infectious aortitis, which remains unclear.Methods The study participants were 32 patients with suspected infectious aortitis who underwent computed tomography and magnetic resonance imaging between September 2020 and November 2022. Sensitivity, specificity, and areas under the curve of each imaging modality were studied using a diagnosis based on a combination of imaging results, clinical symptoms, and laboratory tests. Decision curve analysis was performed to determine the benefit of adding magnetic resonance imaging to computed tomography.Results The median age was 74 years, and 23 participants were men. Fifteen patients (47%) were diagnosed with infectious aortitis. Positive findings for infectious aortitis were identified in 19, 18, and 14 patients by computed tomography, diffusion-weighted whole-body imaging, and the combination of both modalities, respectively. Sensitivity, specificity, and area under the curve for correct diagnosis were 93.3%, 70.6%, and 0.82 (95% confidence interval 0.69–0.95), respectively for computed tomography, 93.3%, 76.5%, and 0.85% (95% confidence interval 0.73%–0.97), respectively for diffusion-weighted imaging, and 86.7%, 94.1%, and 0.90 (95% confidence interval 0.80–0.10), respectively for the combination of both modalities. Decision curve analysis reinforced the clinical benefit of combining the two imaging modalities across all ranges of the probability thresholds.Conclusions Diffusion-weighted whole-body imaging with background body signal suppression is an effective diagnostic tool for infectious aortitis, especially when combined with computed tomography.Clinical Perspective Infectious aortitis is a serious disease that is difficult to accurately diagnose. Although PET-CT is associated with high diagnostic performance, limited access to this modality has encouraged the development of an alternative modality. The whole-body MRI with DWIBS is a more available modality, which is commonly used for cancer diagnosis but is also considered effective in diagnosing infectious diseases. The combination of DWIBS and non-contrast CT yielded a sensitivity of 86.7% (95% CI: 59.5–98.3%), a specificity of 94.1% (95% CI: 71.3–99.9%), and an AUC of 0.90 (95% CI: 0.80–0.10) for the diagnosis of infectious aortitis. DWIBS can be a useful modality as an alternative to PET-CT.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis study was also registered at umin.ac.jp (UMIN R000056536).Funding StatementThe Cardiovascular Surgery Department of East Medical Center provided funding for this study. We confirm that no financial assistance was provided by the manufacturer or distributor of the pharmaceuticals involved in the study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol was developed and approved by the Ethics Committee of Nagoya City University Hospital (control number: 60-22-0112) before data collection and analysis.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data supporting the findings of this study are available from the corresponding author, JS, upon reasonable request.DWIBSdiffusion-weighted whole-body imaging with background body signal suppression;FOVfield of view;TRrepetition time;TEecho time;TIinversion time;PATparallel imaging technique;GRAPPA2generalized autocalibrating partially parallel acquisitions;HASTEhalf-Fourier acquisition single-shot turbo spin-echo;VIBEvolumetric interpolated breath-hold examination;MSCTmultislice computed tomography;ADCapparent diffusion coefficient;DCAdecision curve analysis.